Zurex Pharma Drug Patent Portfolio
Zurex Pharma owns 1 orange book drug protected by 7 US patents Given below is the list of Zurex Pharma's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9844654 | Medical skin applicator apparatus | 24 Apr, 2036 | Active |
| US10688291 | Medical skin applicator apparatus | 20 Dec, 2034 | Active |
| US8389583 | Antimicrobial compositions and methods of use | 09 Aug, 2029 | Active |
| US8703828 | Antimicrobial compositions and methods of use | 23 May, 2028 | Active |
| US9629368 | Antimicrobial compositions and methods of use | 23 May, 2028 | Active |
| US8226971 | Catheter lock solution comprising citrate and a paraben | 06 May, 2025 | Active |
| US9011897 | Catheter lock solution comprising citrate and a paraben | 08 Feb, 2025 | Active |
Latest Legal Activities on Zurex Pharma's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Zurex Pharma.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| 11.5 yr surcharge- late pmt w/in 6 mo, Small Entity | 06 Mar, 2024 | US8226971 |
| Payment of Maintenance Fee, 12th Yr, Small Entity | 06 Mar, 2024 | US8226971 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 26 Dec, 2023 | US10688291 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 05 Oct, 2022 | US9011897 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 06 Oct, 2021 | US8703828 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 21 Jun, 2021 | US9844654 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 25 Sep, 2020 | US9629368 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 21 Aug, 2020 | US8389583 |
|
Recordation of Patent Grant Mailed
Critical
| 23 Jun, 2020 | US10688291 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 23 Jun, 2020 | US10688291 |
|
Email Notification
Critical
| 04 Jun, 2020 | US10688291 |
|
Issue Notification Mailed
Critical
| 03 Jun, 2020 | US10688291 |
| Dispatch to FDC | 26 May, 2020 | US10688291 |
|
Application Is Considered Ready for Issue
Critical
| 26 May, 2020 | US10688291 |
|
Issue Fee Payment Verified
Critical
| 22 May, 2020 | US10688291 |
Zurex Pharma's Family Patents
Zurex Pharma drugs have patent protection in a total of 22 countries. It's US patent count contributes only to 20.9% of its total global patent coverage. 3 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click
below to unlock the full patent family tree.
Zurex Pharma Drug List
Given below is the complete list of Zurex Pharma's drugs and the patents protecting them.
1. Zuragard
Zuragard is protected by 7 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9844654 | Medical skin applicator apparatus |
24 Apr, 2036
(11 years from now)
| Active |
| US10688291 | Medical skin applicator apparatus |
20 Dec, 2034
(10 years from now)
| Active |
| US8389583 | Antimicrobial compositions and methods of use |
09 Aug, 2029
(4 years from now)
| Active |
| US8703828 | Antimicrobial compositions and methods of use |
23 May, 2028
(3 years from now)
| Active |
| US9629368 | Antimicrobial compositions and methods of use |
23 May, 2028
(3 years from now)
| Active |
| US8226971 | Catheter lock solution comprising citrate and a paraben |
06 May, 2025
(4 months from now)
| Active |
| US9011897 | Catheter lock solution comprising citrate and a paraben |
08 Feb, 2025
(a month from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zuragard's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List